Tea (*Camellia sinensis*) has been widely consumed as healthy beverages in the world[@b1]. People worldwide have acknowledged that tea possesses many beneficial effects on their health, particularly the prevention of obesity and the improvement of lipid metabolism[@b2]. Epidemiological data showed that habitual tea consumption can lower the body fat and regulate the plasma lipoprotein constructions[@b3][@b4]. Our previous clinical studies confirmed that the polyphenolic compounds of tea with extraordinary hypolipidemic effects[@b5]. Apart from polyphenols, caffeine is also an important component in tea to promote lipid metabolism. However, the side effects of central nervous system limit the use of caffeine's thermogenic and fat oxidizing properties. Thus, the lipase inhibitory effect of polyphenols has attracted great attention[@b6].

Polyphenols of tea are predominantly catechins and tannins[@b7]. It is also well-known that heat epimerization produces catechin derivatives during processing and extracting such as (−)-epigallocatechin (EGC), (−)-epicatechin-3-gallate (ECG) and (−)-epigallocatechin-3-gallate (EGCG)[@b8]. It has been reported that these catechins and their derivatives possess antioxidant, antiglycemic, anticancer and antilipidemic properties[@b7]. Researchers also reported that theaflavins and the polymerized polyphenols can alter lipid metabolism through inhibiting fatty acid synthesis and enhancing fatty acid oxidation[@b9]. The study of Nakai *et al.* showed theaflavins had stronger inhibitory activities than tea polyphenols. They assumed that the polymerization of flavan-3-ols and/or the galloyl moieties in their structures might be needed for their enhancement of inhibition of pancreatic lipase[@b10]. However, this hypothesis needs more validation. In our study, the docking and 3D-QSAR models were performed to depict the structure-activity relationship between polyphenolic compounds and pancreatic lipase inhibition activities, which might indicate some key information for optimizing hypolipidemic activity of the compounds. The polyphenolic compounds identified the common core structure of EGCG. The models were of satisfactory statistical significance and predictive ability, and we were intrigued by the QSAR and those polymers which gave excellent lipid lowering effect. Using the conformations of the most active compound revealed by molecular docking, a 3D-QSAR pancreatic lipase inhibitor model with good predictive ability was also established and validated by CoMFA and CoMISA methods to further understand the structure-activity relationship between polyphenolic compounds and pancreatic lipase inhibitory activities. In order to get compounds with better activities, the polymerized polyphenols were catalyzed by crude polyphenol oxidase according to the QSAR results which indicate better activity of EGCG's dimer with specific orientation.

Results
=======

Docking analysis of tea flowers polyphenols
-------------------------------------------

The [Fig. 1](#f1){ref-type="fig"} depicts the binding modes between the binding pocket of lipase and compound 8, as well as the alignment of compounds based on the conformation retrieved by docking. The docking conformation of template molecule, compound 8, is shown in [Fig. 1a](#f1){ref-type="fig"}. Based on the benzopyrone ring as the common substructure, we can see all molecules overlap well as in [Fig. 1b](#f1){ref-type="fig"}. The hydroxyl groups at pyrogallol in R~1~ position form a H-bond as an acceptor of hydrogen-bond with the -NH group in the Leu153 and Phe77 residues of lipase, while the other two hydroxyls form H-bonds with Ser152 and Phe77 residues to serve as a donor of hydrogen bond. These observations from [Fig. 1c](#f1){ref-type="fig"} precisely match the acceptor contour maps and the donor of hydrogen bond in the corresponding CoMSIA models.

CoMFA and CoMSIA analysis
-------------------------

Both of the predicted and actual pIC~50~ values of the training and test set compounds are displayed in [Table 1](#t1){ref-type="table"}. The data from CoMSIA and CoMFA models are depicted graphically as scatter diagrams in [Fig. 2a,b](#f2){ref-type="fig"}, respectively. The two diagrams demonstrate an outstanding match of actual and predicted activities. [Table 2](#t2){ref-type="table"} shows the parameters of PLS analysis. The model of CoMFA presents satisfactory leave-one-out cross-validation (*q*^*2*^ value = 0.622), non-cross-validation (*r*^2^ value = 0.956), standard errors of estimate (SEE) of 0.069 and *F* value of 261.463 with an optimal component of 3. The steric field and electrostatic field descriptors explain 44.6% and 55.4% of the variance, respectively. Furthermore, CoMSIA models constitute of descriptors containing steric, hydrophobic and H-bond donors were of a high *q*^*2*^ value (0.631) and *r*^*2*^ value (0.932). Other parameters including the optimal component, SEE and *F* value are 4, 0.122 and 75.408, respectively. Contributions of three selected descriptors are 0.232 for steric, 0.345 for hydrophobic and 0.423 for hydrogen bond donor, respectively.

External validation
-------------------

The external validation is a vital part of the model verification and its *r*^2^~pred~ values calculated based on both training and test set are respectively 0.918 and 0.773 for CoMFA and CoMSIA model ([Table 2](#t2){ref-type="table"}). The favorable external validation parameters indicate that our models are of high accommodating capacities in predicting the pIC~50~ values of new derivatives.

3D Contour maps of QSAR
-----------------------

In this study, compound 8 was used as the template molecule in QSAR models. For CoMFA steric field ([Fig. 3a](#f3){ref-type="fig"}), the green contours (80% contribution) mean these regions are of favorable steric tolerance, and the yellow contours mean 20% contribution for disfavored region. The green contours located around the aromatic ring indicate that this region with bulky substituents would increase the biological activity. That's why the compounds 3, 5 and 16 where hydroxyl is induced in R~2~ show poorer activity than other compounds with bulky substituents. The red and blue contours in [Fig. 3b](#f3){ref-type="fig"} respectively show the favorable locations for the electronegative and electropositive groups. A red contours encircling the carboxyl of benzoyl ring characterize where positively charged substituents are unfavorable. The higher activities of compounds 1, 2, 4, 8 and 11 than other compounds agree with the conclusion of electrostatic fields map.

As to the CoMSIA contours plots, the steric, hydrophobic, hydrogen bond donor fields are dipicted in [Fig. 3c--e](#f3){ref-type="fig"}. The steric contour maps of CoMSIA are alike to those of CoMFA. In hydrophobic counter maps, red (with 80% contribution) and blue (with 20% contribution) contours indicate hydrophobic and hydrophilic favored sites, respectively. A large blue contour can be observed around the R~1~ position, indicating that hydrophilic substituents induced here can enhance the activity. This confirm that compounds with phenol possessed better bioactivity. The red region near the side chain of R~2~ emphasizes a structural preference of hydrophobic substituents. For instance, compounds 1, 8, 10 and 11 whose substituents in R~2~ are ester groups show better activities. Hydrogen bond donor fields are depicted in purple (20%) and cyan (80%) contours for unfavorable and favorable regions, respectively. Cyan contour located near R~2~ indicates hydrogen bond donor induced here can increase the activity of compounds.

Structure-activity relationship
-------------------------------

According to the results of docking and 3D-QSAR, the structure-activity relationship of these polyphenols are summarized in [Fig. 4a](#f4){ref-type="fig"}. Briefly, R~1~ site favors the hydrophilic, hydrogen-bond acceptor groups; the bulky, electron withdrawing groups at R~2~ site are likely to improve the activity; the minor and bulky substituent at R~3~ and R~4~ positions would increase the activity, respectively. Bulky groups at R~5~ position are favored to the activity.

The oxidized tea polyphenol and its inhibitory activity of pancreatic lipase
----------------------------------------------------------------------------

The structure-activity relationship indicates useful information of rationally designing. Under the guidance of the 3D-QSAR results, a compound named (2R,3R,2′R,3′R)-desgalloyloolongtheanin-3,3′-O-digallate (DOTD) was obtained from EGCG oxidative polymerization catalyzed by crude polyphenol oxidase. The structure of DOTD is shown in [Fig. 4b](#f4){ref-type="fig"}. The effect of DOTD on the pancreatic lipase *in vitro* was determined, and results showed that DOTD showed strong lipase inhibition, with an IC~50~ of 0.08 μg/ml.

Activities of DOTD on TG level in olive oil-loaded rats
-------------------------------------------------------

Based on the results from molecular docking, we inferred that DOTD might affect lipid absorption by inhibiting pancreatic lipase, thus converts TG to monoglycerides and free fatty acids. Thus, lipid tolerance test was conducted to determine the influence of DOTD on TG level. [Figure 5a](#f5){ref-type="fig"} shows the chronological changes of TG in blood after oral administration of olive oil to rats. In the control group, the TG level in blood reached the peak at 6 h after administration of olive oil. Comparing to the control group, DOTD (50 and 100 mg/kg) significantly decreased the TG level at the time point of 2, 4, 6 and 8 h. DOTD (50 and 100 mg/kg) showed better effects on decreasing TG level in olive oil-loaded rats than EGCG (100 mg/kg) at the point of 6 and 8 h.

Inhibitory effects of DOTD on lipid absorption in intestine of olive oil-loaded rats
------------------------------------------------------------------------------------

The effects of DOTD on TG level in olive oil-loaded rats might be related with the lipase inhibition. As shown in [Fig. 5b](#f5){ref-type="fig"}, the activities of lipase in both intestine and mucosa contents were obvious higher in intestine section 1 than in section 2 and 3. When DOTD (100 mg/kg) was administrated to rats, the lipase activities were significantly inhibited. These results indicated DOTD with potent lipase inhibitory effect *in vivo*.

Discussion
==========

In the present study, the developed structure-activity relationships on CoMFA, CoMSIA and docking models emphasize different preference of substituent group in all five substituent position ([Fig. 4a](#f4){ref-type="fig"}). Among these indications, the favor groups in R~1~ and R~2~ position gave us major guidelines in our rational improvement of compounds since most field contours are located around this part. Hydrophilic, hydrogen-bond acceptor groups are favorable at R~1~ position. According to the docking analysis, R~1~ substituent form key interaction with lipase by H-bonding. The pyrogallol here with its multiple hydroxy is more beneficial. The bulky, electron withdrawing groups at R~2~ position are most vital in affecting activity. As can be summarized from both activity data and QSAR contour maps, without bulky, electron withdrawing group like galloyl moieties in R~2~ position, the activity is diminished or even vanished. These conclusions also verify the assumption of Nakai *et al.*[@b10].

Along with the information of substituent preference in R~3~ and R~5~ position, we found that the EGCG dimers polymerized in a head-to-head style are of more prominent activity for they precisely match our QSAR results above which indicated bulky, minor, and hydrophilic or electron withdrawing groups in the specific substitute position. As illustrated in [Fig. 6](#f6){ref-type="fig"}, head-to-head polymerization violates no SAR instructions however dimers polymerized in head-to-tail way disobey some inevitably. As to the bulky group preference in R~4~ position, we assumed that galloyl moieties can benefit activity. However, we haven't obtained a 5-O-gallate dimer yet, this hypothesis needs further verification.

The present research indicated that the beneficial effects of EGCG on obesity and associated pathologies are significantly related to its direct and acute effects on lipid metabolism and energy balance. Evidences we obtained demonstrated that EGCG played a predominant role on dietary lipid metabolism both through stimulating their oxidation and reducing their absorption. In this study, the chemical constituents of tea flower, including petal, stamen and pollen were analyzed. The inhibitory activities of TFE against pancreatic lipase by 37 polyphenols from tea flower were examined *in vitro* and obtained satisfactory results. We also established the docking and 3D-QSAR models of lipase inhibition by CoMSIA and CoMFA methods. Statistical significance was obtained in CoMFA (*q*^2^ = 0.622, *r*^2^ = 0.956, *F* = 261.463, SEE = 0.069) and CoMISA (*q*^2^ = 0.631, *r*^2^ = 0.932, *F* = 75.408, SEE = 0.122) model. DOTD was obtained from EGCG oxidative polymerization catalyzed by crude polyphenol oxidase, and showed a potent lipase inhibitory activity. The content of DOTD in tea flower and tea leaves was comparatively lower, which was difficult to be extracted. Akizawa *et al.* extracted DOTD from oolong and named it oolongtheanin 3′-O-gallate[@b10]. However, it could be obtained through enzymatic oxidation under a mild condition. This method could be further optimized to allow mass production.

Materials and Methods
=====================

Chemicals and Regents
---------------------

C, EGC, EC, ECG, EGCG, CG, GC, GCG and all other compounds used in [Table 3](#t3){ref-type="table"} were obtained from Wako Ind. (Osaka, Japan). Olive oil, 4-methylumbelliferyl (4-MU) oleate and type VI-S pancreatic lipase were bought from Sigma-Aldrich (St. Louis, MO, USA).

Animals
-------

Six-week-old SD male rats were obtained from Guangdong Medical Laboratory Animal Center (Guangzhou, China). All the rats were kept in cages and fed with standard chow and water in animal room with controlled illumination (12 h light/dark cycle), humidity (50 ± 5%) and temperature (23 ± 1 °C). All the animal treatments were performed under the "Guideline for the Care and Use of Laboratory Animals" (No. 85--23, revised 1985), published by National Institutes of Health of U.S. All the animal experimental procedures were approved by the Laboratory Animal Ethics Committee of Jinan University (20120910001).

Data set
--------

All polyphenols and their bioactivities were showed in [Table 4](#t4){ref-type="table"}. The demarcation of training and test sets was based on the following criteria as previous report[@b11]: (I) Molecule diversity was statistically significant. (II) The chosen compounds should be of precise and concise information of activity ranges and structure features to eliminate bias or redundancy. (III) The compounds with most and least activities should be arranged in the training set. With the considerations above, all thirty-seven molecules were assigned randomly with the compounds 6, 11, 14, 15, 21, 31 and 37 chosen as the test set. [Table 4](#t4){ref-type="table"} displays the structures of all compounds in the training and test sets. For the convenience in analyzing, the activities of the polyphenols were converted to pIC~50~.

Molecular docking
-----------------

Molecular docking is now widely used in studying ligand-protein interaction and new drug discovery[@b12][@b13][@b14][@b15][@b16]. Many different algorithms were applied in different docking software to explore the affinity of ligands and receptor. In this case, Surflex-Dock in SYBYL 8.1 equipped with an empirical scoring function and a patented search engine was used to dock small-molecules into a protein-active pockets[@b13], and applied to investigate the interactions between the compounds and lipase (PDB code: 1LPB)[@b17]. The idealized hypothetical ligand which makes all potential interactions with the binding site was generated as the protomol with the threshold of 0.5 and bloat of 1 Å, and other parameters are default. Surflex-Dock uses CH~4~, N-H, and C=O fragments as probes to detect into the cavity and gather the information of steric effects and hydrogen-bond sites in the receptor pocket[@b18][@b19]. Before docking, we repaired the side chain, deleted all the water molecules in the crystal structure, then all hydrogen atoms and Gasteiger charges were added[@b20][@b21]. A staged minimization was conducted to optimize the receptor. Using the conditions optimized above, compound 8 was docked into the binding pocket. The total scores are expressed as the logarithm of dissociation constant (lgKd) to characterize binding affinities. Ten conformers with highest scores from docking results were ranked in a spreadsheet file, and we took the configuration with highest total score into further investigation in protein-ligand interaction. The CCP4mg program was applied to depict the interactions between compound 8 and lipase graphically[@b22][@b23].

Molecular modeling and alignment
--------------------------------

All 37 polyphenols' structures shown in [Fig. 7](#f7){ref-type="fig"} and [Table 3](#t3){ref-type="table"} were prepared in sketch module of SYBYL 8.1 (Tripos, Inc., St. Louis, MO, USA). After the construction of molecules, structural energy minimization was conducted by conjugate gradient methods under the conditions of a gradient convergence of 0.05 kcal/(Å mol) in Gasteiger-Hückel charge. The maximum steps of minimization were set to 20000. Alignment is the most essential procedure in building a reliable model. The predictive ability and the statistic quality of 3D-QSAR models are closely related to the alignment[@b24]. Normally, three different aligning methods such as pharmacophore, common substructure and docking overlaps are used to obtain convinced alignment[@b25][@b26]. The compound 8 retrieved from the docking result with the highest active value and reasonable energy (16.205 kcals/mol) was used as the template molecule with benzopyrone ring as the common substructure for its core position and rigid structure.

CoMFA and CoMSIA setup
----------------------

CoMSIA and CoMFA are widely used computational methods in 3D-QSAR modeling which could help us to understand the structures of polyphenolic compounds and guide rational structure modification to obtain novel compounds with more potent activity. With the 3D grid spacing of 2 Å in x, y and z axis, the Coulomb potentials and the Lennard-Jones were applied to calculate the energies of steric and electrostatic field[@b27]. The field values of CoMFA model were detected by a probe atom of a sp[@b3] hybridized carbon with the value cut off set at 30 kcal/mol[@b28][@b29]. For the CoMSIA method, two additional different fields of hydrophobic, hydrogen-bond acceptor were also calculated as an extension of steric and electrostatic fields[@b30]. In CoMSIA method, similarity indices were introduced to make all grid points calculable. The similarity indices were calculated by equation (1):

where *q* is the grid point, and *k* indicates the physicochemical properties of electrostatic and steric descriptors; *W*~*probe,k*~ represents the probe atom and the attenuation factor is a default value of 0.3; *i* means summation index calculating on all atoms of the molecule *j*, and *W*~*ik*~ represents the actual value of physicochemical property *k* of the atom *i*[@b31].

Partial least squares (PLS) analysis
------------------------------------

The PLS analysis was applied to linearly correlate CoMSIA and CoMFA fields to pIC~50~ values. For this analysis[@b32], "leave-one-out" was applied in calculating the cross-validation coefficient (*q*^*2*^) to investigate the robust of the training set. The *q*^2^ is a good indicator of the model fitting and in general, and the *q*^*2*^ value above 0.5 means an acceptable model. Whereafter, the correlation coefficient (*r*^*2*^) was calculated by a non-cross-validation procedure, and the optimized model of 3D-QSAR was generated by using the optimum number of components determined in "leave-one-out". SEE was calculated by equation (2) to test the model.

where, n represents the compounds quantity; c represents the counts of components; PRESS means the sum of squared deviations between the observed and predicted values of test compounds.

External validation
-------------------

The coefficient *q*^2^ is often identified as a benchmark in verifying the model, however it's not always adequate. A model with high *q*^2^ and *r*^2^ values doesn't meant to be absolutely accurate. Even though a model predict the test set precisely enough, the model might perform poorly in predicting when it was applied to another new set of molecules[@b33]. Therefore, a new parameter of external test coefficient (*r*^*2*^~*pred*~) was introduced in assessing the model's predictive ability[@b34]. Predictive values *r*^*2*^~*pred*~ were calculated by the equation (3):

where, SD represents the sum of squared deviations between the activities of test set and training set.

Preparation of oxidized polymerization from tea polyphenols
-----------------------------------------------------------

The leaves of green tea (*C. sinensis*) were collected in April from tea plants which grow in the mountain in Longmen County, Guangdong Province, China. Fresh tea leaves (300 g) of *C. sinensis* were homogenized in a 1000 mL acetone under cooling. The insoluble components were removal by filtration with gauze, and the remaining extract were freeze-dried and stored in −80 °C freezer. Five grams of above extract was suspended in cysteine phosphate buffer (50 mM, pH 6.0) by stirring for 2 h under 5 °C. The solution was centrifuged (12, 000 rpm, 30 min), and the supernatant was treated with 1.0 M ammonium sulfate. The solution was purified with Sephacryl S-300 and Phenyl Sepharose CL-4B. The targeted fraction was dissolved in citric acid--potassium phosphate buffer (0.01 M: 0.02 M, 600 mL, pH 5.6), and applied to the polyphenol oxidase reaction. EGCG (600 mg) was added to the solution of polyphenol oxidase and incubated for 3 h at 32 °C. Then, 90% of CH~3~CN containing 1% TFA (600 mL) was added to stop this reaction. The reaction product was then diluted 5 times with distilled water and eluted on an HP-20 column. After washing with distilled water, 90% CH~3~CN containing 0.1% TFA was used to elute catechins. Three oxidized polyphenols were isolated and purified by prep-HPLC. The structures of the oxidized compounds were identified by MS and NMR analyses as DOTD (18 mg), prodelphinidin B2 (5 mg) and prodelphinidin A2-3′-O-gallate (4 mg). The experiments above were repeated to obtain enough compounds for further studies. MS and NMR data of DOTD were supplied in the [Supporting Information](#S1){ref-type="supplementary-material"}.

Inhibition of pancreatic lipase *in vitro*
------------------------------------------

As a substrate, 4-MU oleate was used to test the activity of pancreatic lipase. A mixture of 4-MU oleate solution (50 μL) and different concentrations of test sample (25 μL) were added in the 96-well microtiter plate. Then, lipase solution (50 U/mL, 25 μL) was added and incubated (30 min, 25 °C). To stop the reaction, sodium citrate solution (0.1 M, 0.1 mL, pH 4.2) was added. The level of the product 4-methylumbelliferone was measured by a fluorescence reader (Tecan, Switzerland, Ex/Em = 355 nm/460 nm). The lipase inhibition rate (%) of each test was calculated by equation (4):

where, F~test~ and F~test\ blank~ respectively represent the fluorescence values of test samples with and without the substrate 4-MU oleate. F~control~ and F~control\ blank~ respectively represent the fluorescence values of control with and without the substrate 4-MU oleate.

IC~50~ of the test samples was calculated on the basis of least-squares regression line of plots of different concentrations (log) against the lipase inhibition rate (%).

Plasma lipid tolerance test
---------------------------

The influence of DOTD on lipid absorption was determined by plasma lipid tolerance test as we previously described[@b35]. Before this experiment, SD rats were starved for 18 h. DOTD (50, 100 mg/kg) was orally administrated to to rats. Thirty min later, olive oil solution was administered orally at a dosage of 5 mL/kg. Rats in control group received the same volume of distilled water. The chronological changes of blood TG levels in rats were analyzed in rats at time point of 0, 2, 4, 6 and 8 h (n = 7 in each group). Blood samples were distilled from an arterial cannula implanted in the abdominal aorta through the femoral artery of rats under anesthesia. The blood was contained in a tube with sodium heparin (2%) and centrifuged (5,000 rpm, 5 min). The supernatants were used to determine plasma TG level by a commercial kit obtained from Nanjing Jiancheng Bioengineering Ltd. (Nanjing, China).

Lipase activity in intestinal mucosa
------------------------------------

Before this experiment, rats were starved for 18 h. Rats were orally loaded with olive oil solution at a dosage of 5 mL/kg. DOTD (100 mg/kg) was administered to rats at 0 or 30 min before olive oil load, or at 30 or 60 min after olive oil load. All the rats were anesthetized 2 h after olive oil administration. The small intestines were taken out and cut into 3 sections. The intestinal digesta and mucosa were obtained and suspended as 5% PBS solution in tubes and centrifuged (10,000 rpm, 10 min)[@b36]. The supernatants were collected to determine the lipase activities as described above. The protein level was determined by Coomassie brilliant blue protein quantitative kit obtained from Nanjing Jiancheng Bioengineering Institute (Jiangsu, China).

Statistical analysis
--------------------

Docking and QSAR statistical results were summarizing together in Sybyl MDE module[@b37][@b38]. Data are expressed as means ± S.D. and analyzed by one-way ANOVA followed by Tukey's *post hoc* test (SPSS Inc, USA). Differences at *P* \< 0.05 are considered as significance.
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![Molecular alignment based on docking results.\
(**a**) Conformation of compound 8 retrieved from docking result; (**b**) Alignment of the training compounds; (**c**) The binding mode between selected compound 8.](srep34387-f1){#f1}

![CoMFA and CoMSIA graphs of actual and predicted pIC50 values.\
(**a**) CoMFA; (**b**) CoMSIA.](srep34387-f2){#f2}

![Contours of CoMFA and CoMSIA analysis with compound 8 as template molecule.\
(**a**) The steric fields of CoMFA. Green contours refer to the regions in which bulky groups elevate activities. Yellow contours suggest the regions in which bulky groups reduce activities; (**b**) The electrostatic fields of CoMFA. The contours in blue and red respectively represent favored regions of electron-donating groups and electron-withdrawing groups; (**c**) The contours in green and yellow respectively indicate bulky and minor groups favored regions; (**d**) Hydrophobic fields of CoMSIA. The contours in blue and red respectively locate the favored hydrophilic and hydrophobic regions; (**e**) Hydrogen-bond donor fields of CoMSIA. The contours in cyan and purple respectively locate the regions in which hydrogen-bond donor groups are favorable and unfavorable.](srep34387-f3){#f3}

![Synthesis guided by SAR.\
(**a**) The Structure-activity relationship analyzed by 3D-QSAR and docking; (**b**) The Structure of DOTD.](srep34387-f4){#f4}

![*In vivo* activity of DOTD.\
(**a**) Effects of DOTD on TG levels in the plasma of rats loaded with olive oil; (**b**) Effects of DOTD on lipase activity in the mucosa and the contents of small intestine of rats loaded with olive oil. Values are expressed as mean ± S.D. (n = 7 in each group). ^\*^*P* \< 0.05, ^\*\*^*P* \< 0.01 vs. control group, and ^†^*P* \< 0.05, ^††^*P* \< 0.01 vs. EGCG group.](srep34387-f5){#f5}

![Head-to-head and head-to-tail polymerization.](srep34387-f6){#f6}

![The basic skeletons of the training and test set compounds in [Table 3](#t3){ref-type="table"}\
. Each structure represents the skeleton of the corresponding molecules in [Table 3](#t3){ref-type="table"}.](srep34387-f7){#f7}

###### Comparison of actual and predicted biological activity in terms of pIC50 of the compounds by using CoMSIA and CoMFA models.

  Compound                          Actual   CoMFA   CoMSIA           
  -------------------------------- -------- ------- --------- ------- --------
  1                                 6.8861   6.758   −0.1281   6.899   0.141
  2                                 6.6778   6.752   0.0742    6.64    −0.112
  3                                 4.5229   4.821   0.2981    4.749   −0.072
  4                                 6.4685   6.201   −0.2675   6.153   −0.048
  5                                 4.5229   4.891   0.3681    4.921    0.03
  6[\*](#t1-fn1){ref-type="fn"}     6.2441   6.123   −0.1211   6.411   0.288
  7                                 6.4089   6.335   −0.0739   6.33    −0.005
  8                                 6.9586   6.771   −0.1876   7.003   0.232
  9                                 6.1308   6.237   0.1062    5.89    −0.347
  10                                6.0132   6.062   0.0488    5.964   −0.098
  11^\*^                            6.7959   6.211   −0.5849   6.312   0.101
  12                                5.9101   5.578   −0.3321   5.563   −0.015
  13                                6.0315   6.732   0.7005    6.542   −0.19
  14[\*](#t1-fn1){ref-type="fn"}    6.1612   6.09    −0.0712   6.002   −0.088
  15[\*](#t1-fn1){ref-type="fn"}    5.5513   6.085   0.5337    6.001   −0.084
  16                                5.0605   5.225   0.1645    5.093   −0.132
  17                                6.7212   6.544   −0.1772   6.523   −0.021
  18                                5.4841   5.154   −0.3301   5.341   0.187
  19                                6.6021   6.66    0.0579    6.614   −0.046
  20                                6.9586   7.05    0.0914    7.059   0.009
  21[\*](#t1-fn1){ref-type="fn"}    6.5229   6.456   −0.0669   6.816    0.36
  22                                5.6402   5.597   −0.0432   5.674   0.077
  23                                5.058    5.066    0.008    5.122   0.056
  24                                5.4841   5.19    −0.2941   5.295   0.105
  25                                4.7622   5.112   0.3498    5.178   0.066
  26                                6.7447   6.765   0.0203    6.944   0.179
  27                                5.4895   5.126   −0.3635   5.272   0.146
  28                                5.6655   5.579   −0.0865   5.481   −0.098
  29                                  7      6.983   −0.017    6.971   −0.012
  30                                5.1643   5.196   0.0317    5.171   −0.025
  31[\*](#t1-fn1){ref-type="fn"}    6.6021   6.977   0.3749    6.959   −0.018
  32                                6.2147   6.396   0.1813    6.076   −0.32
  33                                6.8861   6.805   −0.0811   6.934   0.129
  34                                  7      6.861   −0.139    7.047   0.186
  35                                6.8239   6.768   −0.0559   6.802   0.034
  36                                6.5229   6.599   0.0761    6.565   −0.034
  37[\*](#t1-fn1){ref-type="fn"}    4.7857   5.214   0.4283    5.204   −0.01

^\*^Test set.

###### PLS statistics of the CoMFA and CoMISA 3D-QSAR models.

  PLS               CoMFA    CoMSIA
  --------------- --------- --------
  *q*^2^            0.622    0.631
  *r*^2^            0.956    0.932
  ONC                 3        4
  SEE               0.069    0.122
  F values         261.463   75.408
  Steric            0.446    0.232
  Electrostatic     0.554       
  Hydrophobic                0.345
  H-bond donor               0.423
  *r*^2^~pred~      0.918    0.773

*q*^2^: Cross-validated correlation coefficient. *r*^2^: Non-cross-validated coefficient. ONC: Optimal number of components. SEE: Standard error of estimate. F: F-test value. *r*^2^~pred~: Predictive correlation coefficient.

###### The training and test set compounds.

![](srep34387-t1)

The basic skeletons of these compounds are shown in [Fig. 7](#f7){ref-type="fig"}.

###### Inhibitory Activities of Tea Polyphenols on Pancreatic Lipase.

  No   Compoud Name                                                           IC~50~(μM)   pIC~50~
  ---- --------------------------------------------------------------------- ------------ ---------
  1    assamicain A                                                              0.13      6.8861
  2    assamicain B                                                              0.21      6.6778
  3    (−)-epicatechin (EC)                                                      \>30      4.5229
  4    (−)-epicatechin-3-O-gallate (ECG)                                         0.34      6.4685
  5    (−)-epigallocatechin (EGC)                                                \>30      4.5229
  6    (−)-gallocatechin-3-O-gallate (GCG)                                       0.57      6.2441
  7    (−)-epigallocatechin-3-O-gallate (EGCG)                                   0.39      6.4089
  8    (−)-epigallocatechin-3,5-di-O-gallate                                     0.11      6.9586
  9    (−)-epicatechin 3-O-(3′-O-methyl)-gallat                                  0.74      6.1308
  10   (−)-epigallocatechin-3-O-p-coumaroate                                     0.97      6.0132
  11   (−)-epicatechin(4β-8)-(−)-epigallocatechin 3-O-gallate                    0.16      6.7959
  12   (−)-epigallocatechin (4β-8)-(−)-epicatechin-3-O-gallate                   1.23      5.9101
  13   (−)-epicatechin-3-O-gallate-(4β-8)-(−)-epigallocatechin3-O-gallate        0.93      6.0315
  14   (−)-epigallocatechin-3-O-gallate-(4β-8)-(−)-epicatechin 3-O-gallate       0.69      6.1612
  15   (−)-epiafzelechin 3-O-gallate                                             2.81      5.5513
  16   (+)-catechin (4α-8) (−)-epigallocatechin                                  8.7       5.0605
  17   (+)-catechin (4α-8) (−)-epigallocatechin 3-O-gallate                      0.19      6.7212
  18   (+)-gallocatechin (4α-8) (−)-epicatechin                                  3.28      5.4841
  19   Oolongtheanin                                                             0.25      6.6021
  20   oolonghomobisflavan A                                                     0.11      6.9586
  21   mono-desgalloyl oolonghomobisflavan A                                     0.3       6.5229
  22   di-desgalloyl oolonghomobisflavan B                                       2.29      5.6402
  23   procyanidin B2                                                            8.75      5.0580
  24   procyanidin B3                                                            3.28      5.4841
  25   procyanidin B4                                                           17.29      4.7622
  26   prodelphinidin A2-3′-O-gallate                                            0.18      6.7447
  27   prodelphinidin B2                                                         3.24      5.4895
  28   prodelphinidin B2- 3′-O-gallate                                           2.16      5.6655
  29   prodelphinidin B2-3,3′-di-O-gallate                                       0.1       7.0000
  30   prodelphinidin B4                                                         6.85      5.1643
  31   prodelphinidin B4-3-O-gallate                                             0.25      6.6021
  32   prodelphinidin B5-3,3′-di-O-gallate                                       0.61      6.2147
  33   theaflavin-3′-O-gallate                                                   0.13      6.8861
  34   theaflavin-3,3′-di-O-gallate                                              0.1       7.0000
  35   theasinensin A                                                            0.15      6.8239
  36   theasinensin B                                                            0.3       6.5229
  37   theasinensin C                                                           16.38      4.7857

[^1]: These authors contributed equally to this work.
